+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Survival and prognostic factors in resected N2 non-small cell lung cancer: a study of 140 cases. Leuven Lung Cancer Group



Survival and prognostic factors in resected N2 non-small cell lung cancer: a study of 140 cases. Leuven Lung Cancer Group



Annals of Thoracic Surgery 63(5): 1441-1450



The selection of stage IIIA N2 non-small cell lung cancer patients for primary surgical treatment remains controversial. One hundred forty patients with resected non-small cell lung cancer who eventually proved to have pathologic N2 disease were studied with a univariate and multivariate analysis of prognostic factors. Nineteen patients had a positive mediastinoscopy; the others had a preoperative N0 or N1 stage. Complete resection rate was 80.7%. Five-year survival was 20.8% (95% confidence interval, 17.2% to 24.4%), 32.2% in mediastinoscopy-negative patients. In the univariate analysis, clinical N stage at mediastinoscopy, complete resection, performance status, T stage, number of metastatic levels in adenocarcinoma, and nodal capsule rupture were important factors. In a multivariate model, survival was worse in case of higher T stage (relative risk = 1.43), lower performance status (relative risk = 1.37), involvement of more than one node level (relative risk = 1.68), nonsquamous histology (relative risk = 1.29) and clinical N2 stage (relative risk = 1.43). Long-term survival was unlikely when lactic dehydrogenase or carcinoembryonic antigen levels were elevated. In clinical N0 or N1 cancer, complete resection resulted in reasonable survival prospects. In patients with N2 disease discovered at mediastinoscopy, surgical treatment was only worthwhile in case of minimal N2. Several unfavorable prognostic factors could be identified in the univariate analysis and confirmed in a multivariate Cox model.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 068695698

Download citation: RISBibTeXText

PMID: 9146340

DOI: 10.1016/s0003-4975(97)00314-7


Related references

Survival and prognostic factors in resected N2 non-small cell lung cancer: A study of 140 cases. Annals of Thoracic Surgery 63(5): 1441-1450, 1997

Prognostic factors in patients with resected stage I non-small cell lung cancer. A report from the Lung Cancer Study Group. Cancer 54(9): 1802-1813, 1984

Prognostic importance of the standardized uptake value on (18)F-fluoro-2-deoxy-glucose-positron emission tomography scan in non-small-cell lung cancer: An analysis of 125 cases. Leuven Lung Cancer Group. Journal of Clinical Oncology 17(10): 3201-3206, 1999

A clinico statistical study on 494 cases with lung cancer v. prognostic factors in resected non small cell lung carcinoma. Japanese Journal of Chest Diseases 45(3): 212-219, 1986

Prognostic factors in resected non-small cell lung cancer: an immunohistochemical study of 39 cases. Lung Cancer 16(1): 35-45, 1996

Survival differences by gender for resected non-small cell lung cancer: a retrospective analysis of 12,509 cases in a Japanese Lung Cancer Registry study. Journal of Thoracic Oncology 5(10): 1594-1601, 2010

Survival and prognostic factors in resected cN2-pN0 non-small cell lung cancer. Annals of Thoracic and Cardiovascular Surgery 10(1): 9, 2004

Survival and prognostic factors in resected N0 non-small cell lung cancer. Zhongguo Zhongliu Linchuang 30(3): 187-189, 2003

Mediastinal lymph node staging with FDG-PET scan in patients with potentially operable non-small cell lung cancer: a prospective analysis of 50 cases. Leuven Lung Cancer Group. Chest 112(6): 1480-1486, 1997

Survival and prognostic factors of surgically resected T4 non-small cell lung cancer. Annals of Thoracic Surgery 75(6): 1745-51; Discussion 1751, 2003

Japanese ethnicity compared with Caucasian ethnicity and never-smoking status are independent favorable prognostic factors for overall survival in non-small cell lung cancer: a collaborative epidemiologic study of the National Hospital Organization Study Group for Lung Cancer (NHSGLC) in Japan and a Southern California Regional Cancer Registry databases. Journal of Thoracic Oncology 5(7): 1001-1010, 2010

Survival and prognostic factors in resected satellite-nodule T4 non-small cell lung cancer. Zhonghua Wai Ke Za Zhi 47(2): 120-122, 2009

Recurrence-free survival and prognostic factors in resected pN2 non-small cell lung cancer. European Journal of Cardio-Thoracic Surgery 22(5): 695-700, 2002

Vindesine-ifosfamide-platinum (VIP) induction chemotherapy in surgically staged IIIA-N2 non-small-cell lung cancer: a prospective study. Leuven Lung Cancer Group. Annals of Oncology 9(3): 261-267, 1998

Potential use of FDG-PET scan after induction chemotherapy in surgically staged IIIa-N2 non-small-cell lung cancer: a prospective pilot study. The Leuven Lung Cancer Group. Annals of Oncology 9(11): 1193-1198, 1998